Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in NTLA — Intellia Therapeutics, Inc.

CIK 1595888 NEW YORK, NY
Back to NTLA Full portfolio

Position in NTLA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$225,881
-$4,709,267 QoQ
Shares Held
13,350
-96.5% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#207
of 330 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NTLA Over Time

Shares Held

Position Value (USD)

Derivatives in NTLA

reported options exposure · as of Jun 30, 2026
CallValue
$4,999,860
CallShares
295,500
PutValue
$5,030,316
PutShares
297,300

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,940,661 across 293 Biotechnology names. NTLA ranks #165 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in NTLA

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,030,316 297,300
2026-06-30 $225,881 13,350
2026-06-30 $4,999,860 295,500
2026-03-31 $7,068,948 551,400
2026-03-31 $5,316,454 414,700
2026-03-31 $4,935,148 384,957
2025-12-31 $3,133,914 348,600
2025-12-31 $2,988,914 332,471
2025-12-31 $1,984,093 220,700
2025-09-30 $1,678,644 97,200
2025-09-30 $445,566 25,800
2025-09-30 $3,455,709 200,099
2025-06-30 $181,972 19,400
2025-06-30 $590,940 63,000
2025-06-30 $1,996,345 212,830
2025-03-31 $507,654 71,400
2025-03-31 $1,052,528 148,035
2025-03-31 $270,891 38,100
2024-12-31 $853,512 73,200
2024-12-31 $2,976,284 255,256
2024-09-30 $1,152,855 56,100
2024-09-30 $1,454,940 70,800
2024-09-30 $4,852,408 236,127
2024-06-30 $5,492,632 245,426
2024-03-31 $2,581,317 93,832
2023-12-31 $6,228,648 204,285
2023-09-30 $2,781,832 87,977
2023-06-30 $8,353,333 204,839
2023-03-31 $1,796,451 48,201
2022-12-31 $2,129,091 61,023
2022-09-30 $1,730,898 30,931
2022-06-30 $2,072,987 40,050
2022-03-31 $1,565,819 21,547
2022-03-31 $5,835,401 80,300
2022-03-31 $6,017,076 82,800
2021-12-31 $4,067,456 34,400
2021-12-31 $4,128,230 34,914
2021-12-31 $11,386,512 96,300
2021-09-30 $7,539,230 56,200
2021-09-30 $2,650,937 19,761
2021-09-30 $12,958,890 96,600
2021-06-30 $8,370,585 51,699
2021-06-30 $58,239,027 359,700
2021-06-30 $28,625,688 176,800
2021-03-31 $4,677,019 58,277
2021-03-31 $7,447,664 92,800
2021-03-31 $4,422,050 55,100
2020-12-31 $7,382,080 135,700
2020-12-31 $4,515,200 83,000
2020-12-31 $5,728,918 105,311